Public Health | November 10, 2021
Takeda receives the Arogaya CIBioD Leadership Award
It was recognized for its holistic initiatives designed to improve the quality of life and standards of care for patients
It was recognized for its holistic initiatives designed to improve the quality of life and standards of care for patients
The agreement sharpens the company’s focus on priority medicines in respiratory & immunology portfolio
Ectosense’s NightOwl is a leading cloud-connected home sleep apnea test
Industry leaders to increase patient access to clinical research and scale remote enrollment of participants for trial sponsors to promote increased health equity
It becomes the first ophthalmology biosimilar to gain FDA approval in the United States
Sandoz is committed to building on its leading generic and biosimilar oncology portfolio to further expand patient access while contributing to the sustainability of healthcare systems
TCS provides clinical research services such as clinical data management, regulatory affairs, pharmacovigilance, risk-based monitoring, biostatistics and programming, medical writing, medical affairs and medico marketing, and health economics and outcomes research
The lab has been developed to aid surgeons to overcome the challenging learning curve to obtain laparoscopic expertise
The product can be used by any lab that conducts NGS testing, making precision medicine accessible to all cancer patients
The company has launched Perampil, at 2 mg (Rs. 49/strip of 7 tablets), 4 mg (Rs. 180/strip of 15 tablets) and 6 mg (Rs. 300/strip of 15 tablets) to improve patient access
Subscribe To Our Newsletter & Stay Updated
